Basel Medical Group Ltd Ordinary Shares (BMGL) vs Lucyd, Inc (LUCY)

A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Lucyd, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Basel Medical Group Ltd Ordinary Shares logo
BMGL
Basel Medical Group Ltd Ordinary Shares
$5M
$3.32HealthcareDelayed quote: Oct 6, 2026, 11:48 AM EDT
Lucyd, Inc logo
LUCY
Lucyd, Inc
$6M
$0.93HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT

Total return — BMGL vs LUCY

growth of $100 · dividends reinvested · last 2y
BMGL -94.1% (-75.6%/yr)LUCY -77.2% (-52.3%/yr)LUCY compounded faster over this window
050100Start $1002026$6$23
BMGL LUCY

BMGL vs LUCY: by the numbers

  • •LUCY is the larger company ($6M vs $5M market cap).
  • •Both run net losses; BMGL's is the smaller (-106.78% vs -225.28% net margin).

Metrics side by side

Valuation

MetricBMGLLUCY
P/S ratioN/A1.72
P/B ratio1.070.85

Profitability

MetricBMGLLUCY
Gross margin77.68%22.79%
Operating margin-19.28%-319.16%
Net margin-106.78%-225.28%
ROE-248.66%-111.42%
ROIC-35.07%-122.15%

Growth (annualized)

MetricBMGLLUCY
Revenue CAGR (5Y)N/A64.52%

Go deeper

Full BMGL analysisFull LUCY analysisInteractive comparison tool

Dig into the metrics

Basel Medical Group Ltd Ordinary Shares ROELucyd ROEBasel Medical Group Ltd Ordinary Shares operating marginLucyd operating marginBasel Medical Group Ltd Ordinary Shares revenue growthLucyd revenue growthBasel Medical Group Ltd Ordinary Shares free cash flowLucyd free cash flow

Basel Medical Group Ltd Ordinary Shares & Lucyd appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.